BRAIN PRINT

 

SCROLL

2019/06/04

  • Information

LPIXEL Speaks at the 60th Annual Meeting of the Japanese Society of Neurology

Tokyo, Japan – May 24, 2019 – LPIXEL Inc., a leader in image analysis and processing technology in life science and medical research, is pleased to announce that Yoshiki Soeda, a member of LPIXEL’s Medical Business Department gave a presentation at the 60th Annual Meeting of the Japanese Society of Neurology. During the segment titled, ”To the Ocean of Brain Visualization Research,” Soeda spoke about LPIXEL’s R&D initiatives, highlighting the brain measurement functionalities of the AI-instilled software and the brain aneurysm detection technology.

For more details on the program, please click here.

About LPIXEL
Founded in March 2014, LPixel is a University of Tokyo spin-off that hones its expertise in life science image analysis. LPixel unifies artificial intelligence and its image analysis technologies to develop and provide advanced software for researchers and professionals in the life science industry, including the medical, pharmaceutical and agricultural sectors. LPixel is currently working in collaboration with the University of Tokyo, the National Cancer Center Japan and other research institutions to further the development of its AI-powered medical diagnosis technology. For more information, please visit https://lpixel.net/en/

Contact Details
LPIXEL Inc.
TEL:03-6259-1713
Email:pr@lpixel.net

PRODUCTS

EIRL
Cutting-Edge Technologies that Lead Future Medical Diagnosis
EIRL analyzes a wide range of medical data to provide an accurate and efficient diagnosis. EIRL aims to be the closest partner to all doctors, and serve as another powerful set of eyes to provide top quality medical care.
IMACEL
AI Accelerating
Phase R&D
IMACEL, an image analysis AI, helps to solve various issues in the drug discovery process.
Life science and AI experts support successful AI implementation.

JOINT RESEARCH

PARTNERS

Alphabetical listing

CAREERS

A Third Career Option for Researchers

LPIXEL Inc.